User's Manual
Table Of Contents
- 1. General description
- 2. Indications
- 3. Contraindications
- 4. Warnings and precautions
- 5. Adverse events
- 6. Clinical studies
- 7. Patient selection and treatment
- 8. Patient counselling information
- 9. Declaration of conformity
- 10. Physician guidelines
- 11. Patient information
- 12. How supplied
- 13. Device description
- 14. Implant procedure
- 14.1. Necessary equipment
- 14.2. Packaging
- 14.3. Optional equipment
- 14.4. Before opening the package
- 14.5. Prior to implantation
- 14.6. Device placement
- 14.7. Choosing the type of lead
- 14.8. Shock configuration (+ -> -)
- 14.9. Measurement of thresholds at implant
- 14.10. Leads connection
- 14.11. Device implantation
- 14.12. Tests and programming
- 15. Special modes
- 16. Main functions
- 17. Patient follow-up
- 18. Supplemental Information
- 19. Physical characteristics
- 20. Electrical characteristics
- 21. Programmable parameters
- 22. Non programmable parameters
- 23. Limited warranty
- 24. Patents
- 25. Explanation of symbols
20. ELECTRICAL CHARACTERISTICS
A pacing (%) 100 100 1 15 1 30 0
BiV pacing (%) 100 100 100 100 100 100 0
A, RV Pacing amplitude
(V)
3.5 3.5 3.5 4.5 2.5 2.5 -
LV Pacing amplitude (V) 3.5 3.5 3.5 4.5 2.5 3.0 -
Sensor OFF ON ON ON OFF OFF OFF
Max shocks (42J) per year 4 4 4 4 0 3 4
Longevity (years) 8.2 8.0 9.2 7.6 13.3 11.3 13.6
1h of additional RF programming session reduces the device longevity from 1 to 2 weeks
depending on the device functioning mode (no pacing, 100% pacing). The mean longevity
as a function of shocks delivered at maximum energy, with and without pacing, is as follows:
The mean longevity as a function of yearly remote follow-ups
1
, with and without pacing, is as
follows:
1. An excessive number of remote follow-ups can have a non-negligible impact on device
longevity.
54
SORIN – PLATINIUM CRT-D – U459A